General
H.B. Fuller clears key hurdle in acquisition of Advanced Medical Solutions
The approval moves the $3.5 billion adhesives giant closer to completing its recommended cash acquisition of the UK-based medical technology company
-
By ICN Bureau | August 16, 2026
H.B. Fuller has cleared a major hurdle in its planned acquisition of Advanced Medical Solutions Group plc (AMS), after AMS shareholders voted to approve the proposed deal at specially convened meetings on August 12.
The approval moves the $3.5 billion adhesives giant closer to completing its recommended cash acquisition of the UK-based medical technology company, a transaction the two companies agreed to in June.
"We are pleased with this significant milestone," said Celeste Mastin, president and chief executive officer of H.B. Fuller.
"AMS is an exceptional company and a rare strategic fit that advances our vision for the future of H.B. Fuller. By combining AMS's leading medical technologies, innovation expertise, and regulatory capabilities with H.B. Fuller's global scale and commercial reach, we will create a differentiated healthcare platform positioned for faster growth, stronger margins, and greater value creation. We are excited to welcome the AMS team and begin the next chapter together."
The acquisition would bring AMS's medical technologies, innovation capabilities and regulatory expertise under H.B. Fuller's global platform, strengthening the company's position in healthcare and expanding its reach in medical applications.
